• Product Launch Product Launch

    Product Launch

    Learn more about the new HTG EdgeSeq Autoimmune Panel.

    Learn More

  • Product Launch Product Launch

    Product Launch

    HTG EdgeSeq Reveal - a new data analysis tool from HTG.

    Learn More

  • Product Launch Product Launch

    Product Launch

    Announcing HTG’s new Mouse mRNA Tumor Response Panel.

    Learn More

  • Product Launch Product Launch

    Product Launch

    Learn more about HTG’s new Precision Immuno-Oncology Panel.

    Learn More


HTG EdgeSeq Reveal

“The data analysis completed on the HTG EdgeSeq Reveal software was provided in a timely fashion, and the report that HTG’s bioinformaticians generated for us was detailed, complete, and easy to understand.” 

Dr. Steven A. Porcelli,
Professor and Chair, Department of Microbiology & Immunology,
Weinstock Professor of Microbiology & Immunology,
Scientific Director, Einstein Flow Cytometry Core Facility,
Albert Einstein College of Medicine

Learn More

A Revolution in Molecular Profiling

Our next-generation sequencing (NGS)-adapted chemistry and instrument platforms automate sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets from samples a fraction of the size required by competitive technologies, enabling customers to do more molecular profiling with less sample.

Learn More

KOL Luncheon:
Breast Cancer Molecular Diagnostics

Hosted by HTG, the event featured a presentation by Adam Brufsky, MD, PhD (Co-Director, Comprehensive Breast Cancer Center and Medical Director, Woman’s Cancer Center at the UPMC Magee Women’s Hospital, Pittsburgh PA), who discussed the current challenges in diagnosing breast cancer and unmet medical needs and optimizing treatment. Dr. Brufsky answered questions at the conclusion of the event.

HTG Molecular Diagnostics' management team provided an update of their development plan to build a comprehensive breast cancer diagnostic platform. This plan showcased the product roadmap and milestones demonstrating the company’s progresses towards assays that can help clinicians improve the care of cancer patients.

View Slides

News & Events

Molecular Med Tri-Con

Meet HTG at the Molecular Med Tri-Con

Posted on:

Keep Reading

American Society of Clinical Oncology (ASCO) 2020

Meet us at our booth 20161!

Posted on:

Keep Reading

USCAP 2020 Customer Presentation by Dr. Leonie AS Frauenfeld

Presentation Background: Diffuse large B-cell lymphoma (DLBCL) is the most common NHL in adults. Gene expression profiling (GEP) divides DLBCL according to the cell of origin (COO) into three subgroups: GCB, ABC and unclassifiable (UNC), exhibiting different mutational profiles.

Posted on:

Keep Reading

USCAP 2020 Customer Poster by Dr. Michael J. Hwang

Sarcomatoid Renal Cell Carcinoma Demonstrates an Immunosuppressive Tumor Microenvironment – Implication for Therapeutic Benefit in the Immunotherapy Era

Renal cell carcinoma (RCC) with sarcomatoid features (sRCC) is an aggressive form of RCC with poor response to conventional therapies. Immune checkpoint inhibitors have shown promising therapeutic effect for sRCC in recent small series and sRCC has demonstrated higher PD-L1 expression and PD-1 positive tumor-infiltrating lymphocytes compared to high-grade clear cell RCC (ccRCC). Our aim was to use multiplexed gene expression assays to gain a broader view of the underlying tumor microenvironment in sRCC.

Posted on:

Keep Reading

HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference

TUCSON, Ariz. , Feb. 19, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the SVB Leerink 9 th Annual

Keep Reading

Read the latest news about HTG’s CDx plans and other alliances!

Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances

Posted on:

Keep Reading

Careers at HTG

At HTG Molecular Diagnostics, Inc., we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

Featured Positions

Sr. Manager, Life Sciences Molecular Testing Laboratory

Database Administrator - Tucson

New Careers

HR Generalist - Tucson

See All Careers


Find product information, specifications and gene lists here. 


Gene Lists

Product Sheets

Tech Notes

Safety Data Sheets



Read white papers or journal publications and view other scientific content. 

White Papers




Peer Reviewed Publications



Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or assays. 

Product Launch Files

User Manuals RUO

User Manuals CE-IVD

Package Inserts RUO

Package Inserts CE-IVD

Training Modules RUO

Training Modules CE-IVD

Page last updated November 19, 2019

Ready to get started?

HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.

Get in Touch